Summary D-Psicose is a rare sugar present in small quantities in natural products. In a previous study, we showed that D-psicose suppresses plasma glucose increases and reduces body fat accumulation in rats. Based on acute toxicity testing in rats, D-psicose is classified as an ordinary substance (LD50 = 16 g/kg). Elucidating the effects of long term feeding of Dpsicose in rats will be essential prior to its utilization as a physiologically functional food. In this study, male Wistar rats (3 weeks old) were fed diets containing 3% D-psicose or sucrose for 12-18 months. The rats actually ingested 1.28 g/kg body weight per day D-psicose or 1.22 g/kg body weight per day of sucrose. Body weight gain and intra-abdominal adipose tissue weight in rats fed the D-psicose diet for 18 months were significantly lower than those in rats fed the sucrose diet. Relative weights of liver and kidney were significantly higher in the Dpsicose group than in the sucrose group. However, no gross pathological findings were evident at dietary doses of 3% D-psicose or correlated with hypertrophy of liver and kidney. No clinical chemical test value was suggestive of overt D-psicose treatment-related toxicity. Therefore, the present study found no adverse effects at 3% D-psicose in the diet.
Introduction
D-psicose (D-ribo-2-hexulose), a C-3 epimer of Dfructose, is a "rare sugar" present in small quantities in commercial mixtures of D-glucose and D-fructose obtained from hydrolysis of sucrose or isomerization of D-glucose [1] . D-psicose is also present in processed cane and beet molasses [2] , and is found in wheat [3] , Itea plants [4] , and in the antibiotic psicofranine [5] . Because of the very small amounts of D-psicose in natural products, few studies have examined D-psicose metabolism in animals.
Recently, we developed a new method to produce Dpsicose enzymatically on a large scale [6, 7] , making it possible to conduct studies of bioactivity and applications in food and medicine. Examining the effects of D-psicose on glucose and lipid metabolisms, we found that D-psicose is a sweet monosaccharaide that provides no energy to growing rats and leads to less intra-abdominal fat accumulation than D-glucose and D-fructose in rats [8, 9] . In addition, we have suggested that supplemental D-psicose can lower plasma glucose levels [10] .
Based on acute toxicity testing in rats, D-psicose is classified as an ordinary substance; the LD50 value was 16 g/kg orally in rats [11] . D-psicose, which is contained in foods such as fruit juice and fruit cereal, is derived from D-fructose in the cooking process [2, 12] . Thus, most humans ingest a limited amount of D-psicose on a daily basis. However, the effects of long-term feeding of Dpsicose must be elucidated prior to utilization as a physiologically functional food.
In this study, to assess D-psicose safety, oral 12-month and 18-month toxicity studies were conducted with rats at dietary doses of 3% D-psicose. The objective was to determine whether or not D-psicose can be used as a food.
Materials and Methods
All procedures involving animals were approved by the Animal Care Committee of the Kagawa University.
Animals and experimental diets
Thirty-six male Wistar rats (3 weeks old) were obtained from Japan SLC (Shizuoka, Japan). They were fed CE-2, a commercial rodent diet (CLEA, Tokyo, Japan) and water ad libitum until they were 4 weeks old. They were caged individually at 22 ± 2°C, with light from 08:00 to 20:00 h. The rats were randomly divided into two groups of 18 (the sucrose and D-psicose groups). We adopted sucrose as a control of D-psicose because sucrose is a most popular sweet carbohydrate and is used in many studies as control saccharide [13] [14] [15] . The experimental diets were 3% sucrose or D-psicose added to the CE-2. The amount of test carbohydrates (3%) was decided in reference to previous studies concerning sucralose with the LD50 level (16 g/kg weight) same as D-psicose [11, 16, 17] . Each group of rats was given free access to the food and water for 12 or 18 months. Dpsicose was donated by the Rare Sugar Center of Kagawa University. Sucrose was purchased from Wako Pure Chemical Industries (Osaka, Japan).
Experimental Design
After 12 months of feeding, 8 rats in each group were fasted 4.5 h from 06:00 h, then anesthetized with intraperitoneal administration of sodium pentobarbital. Blood was collected from the abdominal aorta for clinical hematological analysis and to obtain serum for chemical analysis. The rats were allowed to exsanguinate. The remainders of the rats (10 rats in each group) were killed at the end of 18 months in a similar manner. The brain, heart, lungs, liver, pancreas, kidneys, adrenals, spleen, testicles, intra-abdominal adipose tissues (epididymal, perirenal and mesenteric) and muscle tissues (soleus, gastrocnemius and plantarius) were quickly removed and weighed. Parts of the liver and kidney were preserved in 10% neutral buffered formalin for histopathological examinations. The stomach, small intestine, large intestine and cecum were also quickly removed and weighed. In addition, the small and large intestine length, surface area and cecal content weight were measured.
Analysis
The following hematological and clinical chemistry parameters were evaluated platelet count (PLT), hemoglobin (Hb), erythrocyte count (RBC), leukocyte count (WBC), hematocrit (HCT), mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC), glucose (GLU), insulin (ISL), triglycerides (TG), free fatty acids (FFA), total cholesterol (CHO), aspartate aminotransferase (AST), alanine aminotransferase (ALT), total bilirubin (TBIL), direct bilirubin (DBIL), indirect bilirubin (IBIL), creatinine (CREA), urea nitrogen (BUN), uric acid (UA), albumin (ALBU), total protein (TP), ratio of albumin and globulin (A/G), lipid peroxide (LPO), Ca, and Fe. Hematological analysis was requested from SRL Co., Ltd. (Tokyo, Japan). Concentrations of serum glucose, triglycerides and peroxide lipid were determined by methods reported previously [18] [19] [20] . Serum insulin concentration was determined using a kit (Rat Insulin EIA System, Amersham Bioscience, Tokyo, Japan). Serum iron concentration was measured by flame atomic absorption spectrophotometry (AAS Z-5000, Hitachi, Tokyo, Japan) after diluted samples with 0.1 M HNO3. Other analyses of clinical chemistry were determined using a kit (Wako Pure Chemical Industries, Osaka, Japan). Evaluation of histopathological examinations was requested from Fuji Biomedix (Yamanashi, Japan). Then, histopathological levels in each rat were subjectively quantified as follows score: (−;0, ±;1, +;2, ++;3, +++;4).
Statistical analysis
All values were expressed as mean ± SD. Statistical analysis of differences between the sucrose and D-psicose groups was performed with Student's t test. Statistical significance was set at p value of <0.05. All analyses were performed with a commercially available statistical package (Stat View J-5.0, SAS Institute Inc., Cary, NC).
Results

Body and tissue weights, energy intake and digestive tract size
Results of body and tissue weights, energy intake and digestive tract size in rats fed for 12 or 18 months are presented in Tables 1 and 2 , respectively. Final body weight, weight gain and energy intake did not differ between the sucrose and the D-psicose group at 12 months (Table 1) . At 18 months, final body weight and weight gain in the Dpsicose group were significantly lower than in the sucrose group, through energy intake did not differ between the 2 groups ( Table 1 ). The rats actually ingested 1.28 g/kg body weight per day D-psicose or 1.22 g/kg body weight per day of sucrose. Livers and kidneys at 12 months were significantly heavier in the D-psicose group than in the sucrose group, but no differences were observed in any other tissue weights (Table 1 ). Livers and kidneys at 18 months were also significantly heavier in the D-psicose group than in the sucrose group, and higher weights were also observed in brains, lungs and pancreas in the D-psicose group compared to the sucrose group (Table 1) . In contrast, relative intraabdominal adipose tissues at 18 months were significantly lighter in the D-psicose group than in the sucrose group (Table 1) . Digestive tract size in rats fed for 12 months did not differ between the sucrose and the D-psicose group (Table 2) . Cecal content weight in rats fed for 18 months was significantly higher in the D-psicose group than in the sucrose group, but no differences were observed in size (Table 2) .
Hematological values
Hematology results in rats fed for 12 or 18 months are presented in Table 3 . MCH at 12 months was significantly lower in the D-psicose group than in the sucrose group, but no differences were observed in any of the related hematology values (Table 3 ). Hb and MCV at 18 months were significantly greater in the D-psicose group than in the sucrose group, but no differences were observed in any of the related hematology values (Table 3) .
Clinical chemistry
Serum chemical analysis results from rats fed for 12 months are presented in Table 4 . All chemical values did not differ between the sucrose and D-psicose groups (Table 4) .
Histopathological examination
Histopathological observations of the liver and kidneys are presented in Tables 5 and 6 , respectively. Age-related naturally occurring lesions were observed in the liver and kidneys at 12 months, but no abnormality due to ingestion of D-psicose was observed (Table 5) . Histopathologic observation of the liver at 18 months, revealed fatty degeneration and hepatocellular fibrosis were observed in the D-psicose group and not in the sucrose group (Table 6 ). These findings tended to be slight and local. The hepatocellular fibrosis observed in one sample of the D-psicose group (out of 8 samples) was extremely mildly. Histopathological observation at 12 months showed no difference in total pathological lesions between the sucrose and the D-psicose groups (Liver, 4.13 vs 3.13; Kidney, 12.3 vs 14.1 (Mean scores)) ( Table 5 ). In the liver at 18 months, the mean value for pathological lesions was significantly higher in the DPsicose group than in the sucrose group (2.75 vs 3.75 (Mean scores)), but the difference was slight (p<0.0498) ( Table 6 ).
In the kidneys at 18 months, the total value for pathological lesions did not differ between the sucrose and the D-psicose groups (14.0 vs 14.1 (Mean scores)) ( Table 6) .
Discussion
The present study demonstrated that the effects of 3% Dpsicose in the diet after long-term administration to rats were increased relative weights of liver and kidneys. However, hematological, chemical and histopathological examinations 
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Thickening of Bowman's capsule basement membrane ± ++ ± ± + ++ ± + + + + + ± ± ++ ± ++ Lymphocyte infiltration in the interstitium + ++ ± ± ± ++ ± ++ + ++ +++ ± + ++ ± ++ revealed no values suggestive of overt D-psicose treatmentrelated toxicity. Previous testing found that the LD50 value of D-psicose orally in rats was 16 g/kg [11] . In the present study, rats actually ingested 1.28 g/kg body weight per day of Dpsicose or 1.22 g/kg body weight per day of sucrose. Body weight gain and intra-abdominal adipose tissue weight in rats fed the D-psicose diet for 18 months were significantly lower than those in rats fed the sucrose diet. We previously reported that D-psicose supplements suppress hepatic lipogenic enzyme activity and reduce intra-abdominal fat accumulation more effectively than D-glucose or D-fructose supplements in rats [9, 21] . In addition, we found that Dpsicose is a sweet monosaccharide that provides no energy to growing rats [8] . The present findings support our previous results. However, rats fed the D-psicose diet for 12 months did not differ from the sucrose group in most parameters studied, which indicates that D-psicose did not inhibit rat growth. Thus, low dietary levels (3% of diet or less) of D-psicose over an extended period primarily affected fat accumulation.
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In a previous short-term toxicity test in rats, we showed that the feeding of diets extremely high in D-psicose appeared to be harmful to the intestinal tract [11, 22] . Moreover, we previously reported that cecal weight, cecal surface area and cecal content weight increased with increases of D-psicose in diets (above 10%) [11, 22] . D-psicose is partly absorbed in the digestive tract and is excreted into urine and feces. However, it is also fermented in the cecum by intestinal microflora, producing short-chain fatty acids as a soluble dietary fiber [22, 23] . In this study, no adverse effects on the intestinal tract were seen at 3% D-psicose in the diet at 12 months. However, cecal content weight in the D-psicose group at 18 months was significantly higher than in the sucrose group. These findings suggest that short-chain fatty acids due to intestinal fermentation accumulated in the cecum during long-term administration of D-psicose. Thus, 3% D-psicose in the diet does not appear to be harmful to the intestinal tract. Sucralose, a low-calorie artificial sweetener and with the acute-toxicity of the level same as D-psicose, has also been reported to increase cecal weight in the shortterm toxicity test, but this has been recognized as a non-toxic effect [16] .
In this study's hematological analysis, dietary D-psicose significantly decreased the MCH value at 12 months compared to sucrose, and significantly increased the Hb and MCV values at 18 months. These findings suggest no overt D-psicose toxicity, because the values remain within the normal range.
Dietary D-psicose increased the weights of livers and kidneys. This finding agrees with our previous studies [10, 11, 24] . Bilirubin, a bile pigment, is produced from hemoglobin and is used as an index of hepatic function.
Blood bilirubin concentration increases when hepatopathy and homolytic disease occurs. Blood levels of AST and ALT are also used as indexes of hepatic damages. These values in this study did not differ between D-psicose and sucrose. In addition, histopathologic observations of the liver and kidneys revealed no abnormalities due to ingestion of D-psicose. Liver enlargement occurs in animals and humans under a variety of conditions with different consequences for health [25] . For example, it can be the result of a physiological adaptation to an enhanced workload or metabolic demand, a metabolic abnormality, a toxic effect, an inflammatory process, or a proliferative disease. Bar et al. [26] found that D-tagatose, a rare sugar, increases liver glycogen deposition and relative liver weights in non-fasting rats at dietary levels of 5-20%. D-tagatose is an incompletely absorbed ketohexose (stereo isomer of D-fructose) that has potential as an energy-reduced alternative sweetener. Bar et al. concluded that the liver enlargement seen in response to the consumption of D-tagatose was a physiological response to treatment-induced increased glycogen deposition. We previously found some D-psicose treatmentinduced increase in glycogen deposition (unpublished dates). However, these results lacked clarity. It is unknown whether these mechanisms of the liver enlargement induced by D-psicose and D-tagatose are the same.
Final body weights of both sucrose and D-psicose groups were lower at 18 months than at 12 months. The cause of weight reduction is regarded as a decrease of energy intake by the aging. However, why the weight reduction ratio of D-psicose group is greater than that of sucrose group is not clear.
In conclusion, the present study found the effects of longterm 3% D-psicose administration to rats to be increased liver and kidney weights with no gross pathological findings correlated with this hypertrophy. Hematological and chemical values were not suggestive of overt D-psicose toxicity. Overall, no adverse effects were seen at this low-dose of D-psicose in the diet.
